Fidelity National Financial Inc. decreased its holdings in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Free Report) by 12.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,680,307 shares of the company’s stock after selling 525,000 shares during the quarter. Crescent Capital BDC comprises approximately 1.3% of Fidelity National Financial Inc.’s holdings, making the stock its 3rd largest position. Fidelity National Financial Inc. owned about 9.99% of Crescent Capital BDC worth $33,785,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the business. Rivernorth Capital Management LLC acquired a new stake in Crescent Capital BDC in the 2nd quarter valued at approximately $7,675,000. North Ground Capital acquired a new position in shares of Crescent Capital BDC during the second quarter worth approximately $5,687,136. Beach Point Capital Management LP lifted its holdings in shares of Crescent Capital BDC by 1,301.2% during the third quarter. Beach Point Capital Management LP now owns 515,892 shares of the company’s stock worth $4,736,000 after buying an additional 479,075 shares during the last quarter. Almitas Capital LLC acquired a new position in shares of Crescent Capital BDC during the second quarter worth approximately $3,897,000. Finally, Aspen Grove Capital LLC boosted its position in shares of Crescent Capital BDC by 0.9% in the first quarter. Aspen Grove Capital LLC now owns 269,852 shares of the company’s stock valued at $3,279,000 after acquiring an additional 2,434 shares during the period. Institutional investors own 49.46% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on CCAP shares. Wall Street Zen upgraded shares of Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Saturday, October 10th. Keefe, Bruyette & Woods cut shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and reduced their target price for the company from $13.00 to $12.00 in a research note on Monday, August 17th. Bank of America downgraded Crescent Capital BDC from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $13.00 to $10.25 in a research report on Thursday, September 10th. Ladenburg Thalmann & Co. Inc. lowered Crescent Capital BDC from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a research note on Wednesday, November 11th. Finally, Zacks Research raised Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 21st. Seven equities research analysts have rated the stock with a Hold rating. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $11.54.
Check Out Our Latest Research Report on CCAP
Crescent Capital BDC Stock Performance
NASDAQ:CCAP opened at $10.13 on Monday. The company has a 50-day moving average of $9.43 and a 200-day moving average of $11.47. Crescent Capital BDC, Inc. has a 52 week low of $8.40 and a 52 week high of $15.18. The company has a market capitalization of $373.25 million, a price-to-earnings ratio of -1,013.00 and a beta of 0.56.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last posted its earnings results on Monday, November 9th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Crescent Capital BDC had a negative net margin of 0.10% and a positive return on equity of 8.74%. The business had revenue of $36.89 million for the quarter, compared to analysts’ expectations of $36.37 million. Sell-side analysts forecast that Crescent Capital BDC, Inc. will post 1.45 EPS for the current year.
Crescent Capital BDC Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Thursday, December 31st will be paid a $0.34 dividend. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $1.36 annualized dividend and a yield of 13.4%. Crescent Capital BDC’s payout ratio is currently -13,600.00%.
Insider Buying and Selling
In other Crescent Capital BDC news, major shareholder & Guaranty Life Insur Fidelity sold 139,054 shares of the company’s stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $10.23, for a total value of $1,422,522.42. Following the sale, the insider directly owned 3,680,307 shares in the company, valued at $37,649,540.61. This represents a 3.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 451,543 shares of company stock valued at $4,689,738. 1.23% of the stock is owned by insiders.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc. is a business development company that provides financing to middle-market businesses. It is externally managed by Crescent Capital Group LP, an alternative credit investment manager. The company invests primarily in debt, including first- and second-lien senior secured loans and subordinated debt, and may also make equity investments. Its portfolio focuses mainly on U.S. companies. Crescent Capital BDC began investment operations in 2015. Through its financing activities, it aims to support the business needs of middle-market companies, including growth and other strategic initiatives.
See Also
- Five stocks we like better than Crescent Capital BDC
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.
